Business Context and Reporting Period
This Form 8-K was filed by AMP Holding Inc. (noted in metadata as Workhorse Group Inc.) on March 18, 2014. The report details a material definitive agreement and unregistered sales of equity securities involving a private placement transaction with an existing shareholder and accredited investor, Joseph T. Lukens.
Key Financial Metrics and Transaction Details
- Total Commitment: $3,000,000 in consideration for 30,000,000 shares of common stock and warrants to acquire 15,000,000 shares.
- Funding Status: $1,200,000 funded to date ($685,000 in late 2013; $515,000 in Q1 2014).
- Remaining Obligation: $1,800,000 committed to be funded between March 18, 2014, and May 18, 2014.
- Securities Issued to Date: 12,000,000 shares of common stock and warrants for 6,000,000 shares.
- Warrant Terms: Exercisable for three years at an exercise price of $0.15 per share.
Note: The filing does not provide general revenue, profit, cash flow, margin, or debt metrics for the company.
Material Changes
The primary material change is the entry into a Subscription Agreement resulting in the issuance of equity and warrants. This transaction represents a significant capital raise event, increasing the company's share count and potential future dilution upon warrant exercise.
Guidance, Outlook, and Risks
Outlook: Management expects to receive the remaining $1.8 million in funding by May 18, 2014, contingent on the investor's commitment.
Risks and Contingencies:
- The transaction relies on exemptions from registration under Section 4(2) and Rule 506 of the Securities Act of 1933.
- Future funding is dependent on the investor's ability to meet the committed schedule.
- The filing explicitly states that the summary is not complete and is qualified by the full text of the attached agreements.
Investor Verification Checklist
- Verify the full text of the Subscription Agreement (Exhibit 4.1) and Warrant (Exhibit 4.2) for specific covenants and conditions.
- Confirm the actual receipt of the remaining $1.8 million funding by the May 18, 2014 deadline.
- Assess the impact of the 30,000,000 new shares and 15,000,000 warrant shares on existing shareholder dilution.
- Review the company's broader financial health in subsequent filings, as this 8-K does not contain operational financial data.